Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (3): 277-281.DOI: 10.3969/j.issn.1673-8640.2024.03.012
Previous Articles Next Articles
LUO Lili, LIU Xiaohui, HAO Jianjun, WANG Lili, LUO Jiao, CHEN Qimei()
Received:
2022-07-29
Revised:
2023-11-12
Online:
2024-03-30
Published:
2024-04-24
CLC Number:
LUO Lili, LIU Xiaohui, HAO Jianjun, WANG Lili, LUO Jiao, CHEN Qimei. Efficiency of serum homocysteine,BNP and fibrinogen for deep venous thrombosis of lower extremity after cesarean section[J]. Laboratory Medicine, 2024, 39(3): 277-281.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.03.012
组别 | 例数 | 年龄/岁 | 体重/kg | 初产产妇/例 | 经产产妇/例 |
---|---|---|---|---|---|
DVT组 | 37 | 28.61±5.33 | 69.45±8.21 | 30 | 7 |
健康对照组 | 37 | 28.22±5.54 | 70.63±9.32 | 24 | 13 |
疾病对照组 | 30 | 28.05±5.87 | 68.88±9.98 | 22 | 8 |
统计值 | 0.411 | -0.618 | 0.511 | 0.511 | |
P值 | 0.821 | 0.676 | 0.447 | 0.447 |
组别 | 例数 | 年龄/岁 | 体重/kg | 初产产妇/例 | 经产产妇/例 |
---|---|---|---|---|---|
DVT组 | 37 | 28.61±5.33 | 69.45±8.21 | 30 | 7 |
健康对照组 | 37 | 28.22±5.54 | 70.63±9.32 | 24 | 13 |
疾病对照组 | 30 | 28.05±5.87 | 68.88±9.98 | 22 | 8 |
统计值 | 0.411 | -0.618 | 0.511 | 0.511 | |
P值 | 0.821 | 0.676 | 0.447 | 0.447 |
组别 | 例数 | Hcy/(μmol·L-1) | BNP/(pg·mL-1) | Fib/(g·L-1) |
---|---|---|---|---|
DVT组 | 37 | 17.98±1.78 | 629.76±55.65 | 5.41±0.47 |
健康对照组 | 37 | 13.07±1.43 | 361.34±54.65 | 3.21±0.46 |
疾病对照组 | 30 | 17.34±1.97 | 618.74±63.14 | 5.21±0.61 |
F值 | 8.147 | 6.458 | 4.454 | |
P值 | 0.041 | 0.034 | 0.027 |
组别 | 例数 | Hcy/(μmol·L-1) | BNP/(pg·mL-1) | Fib/(g·L-1) |
---|---|---|---|---|
DVT组 | 37 | 17.98±1.78 | 629.76±55.65 | 5.41±0.47 |
健康对照组 | 37 | 13.07±1.43 | 361.34±54.65 | 3.21±0.46 |
疾病对照组 | 30 | 17.34±1.97 | 618.74±63.14 | 5.21±0.61 |
F值 | 8.147 | 6.458 | 4.454 | |
P值 | 0.041 | 0.034 | 0.027 |
组别 | 例数 | Hcy/(μmol·L-1) | BNP/(pg·mL-1) | FIB/(g·L-1) |
---|---|---|---|---|
健康对照组 | 37 | 13.07±1.43 | 361.34±54.65 | 3.21±0.46 |
轻度组 | 16 | 16.26±1.44* | 570.55±51.88* | 4.99±0.45* |
中度组 | 15 | 18.08±1.51*# | 654.34±50.39*# | 5.51±0.48*# |
高度组 | 6 | 22.32±1.47*#△ | 726.20±52.12*#△ | 6.28±0.51*#△ |
F值 | 95.994 | 172.182 | 149.171 | |
P值 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | Hcy/(μmol·L-1) | BNP/(pg·mL-1) | FIB/(g·L-1) |
---|---|---|---|---|
健康对照组 | 37 | 13.07±1.43 | 361.34±54.65 | 3.21±0.46 |
轻度组 | 16 | 16.26±1.44* | 570.55±51.88* | 4.99±0.45* |
中度组 | 15 | 18.08±1.51*# | 654.34±50.39*# | 5.51±0.48*# |
高度组 | 6 | 22.32±1.47*#△ | 726.20±52.12*#△ | 6.28±0.51*#△ |
F值 | 95.994 | 172.182 | 149.171 | |
P值 | <0.001 | <0.001 | <0.001 |
指标 | 曲线下面积(95%可信区间) | 最佳临界值 | 敏感性/% | 特异性/% | 阳性预测值/% | 阴性预测值/% |
---|---|---|---|---|---|---|
Hcy | 0.912(0.817~0.961) | 14.56 μmol·L-1 | 86.49 | 89.19 | 88.89 | 86.84 |
BNP | 0.861(0.789~0.925) | 500.00 pg·mL-1 | 81.08 | 83.78 | 83.33 | 81.58 |
Fib | 0.877(0.801~0.933) | 4.94 g·L-1 | 85.14 | 87.84 | 87.50 | 85.53 |
联合检测 | 0.946(0.876~0.988) | 91.89 | 94.59 | 94.44 | 92.11 |
指标 | 曲线下面积(95%可信区间) | 最佳临界值 | 敏感性/% | 特异性/% | 阳性预测值/% | 阴性预测值/% |
---|---|---|---|---|---|---|
Hcy | 0.912(0.817~0.961) | 14.56 μmol·L-1 | 86.49 | 89.19 | 88.89 | 86.84 |
BNP | 0.861(0.789~0.925) | 500.00 pg·mL-1 | 81.08 | 83.78 | 83.33 | 81.58 |
Fib | 0.877(0.801~0.933) | 4.94 g·L-1 | 85.14 | 87.84 | 87.50 | 85.53 |
联合检测 | 0.946(0.876~0.988) | 91.89 | 94.59 | 94.44 | 92.11 |
[1] | 尚清, 邢小芬, 李军霞, 等. 低分子肝素钙联合丹参注射液对剖宫产术后下肢深静脉血栓患者凝血功能及D-二聚体水平影响[J]. 热带医学杂志, 2018, 18(6):766-768. |
[2] | 黎先萍, 李娟. 血清D-二聚体、同型半胱氨酸及Wells评分对剖宫产术后并发下肢深静脉血栓的临床预判价值[J]. 现代预防医学, 2017, 44(22):4214-4217. |
[3] | 袁武锋, 蒋雷, 郑素洁. 尿激酶溶栓治疗对下肢深静脉血栓合并急性肺栓塞患者凝血功能、D-二聚体、N-末端脑钠肽前体的影响[J]. 中华全科医学, 2017, 15(12):2068-2070. |
[4] |
FOLSOM A R, LUTSEY P L, HECKBERT S R, et al. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism[J]. J Thromb Haemost, 2018, 16(10):1964-1972.
DOI PMID |
[5] |
WANG Z, XIAO J, ZHANG Z, et al. Chronic kidney disease can increase the risk of preoperative deep vein thrombosis in middle-aged and elderly patients with hip fractures[J]. Clin Interv Aging, 2018, 13:1669-1674.
DOI PMID |
[6] | 中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中华普通外科杂志, 2017, 32(9):807-812. |
[7] | 康联宗, 肖金玉, 陶芸. D二聚体和纤维蛋白原联合检测在下肢深静脉血栓形成中的诊断效果[J]. 血栓与止血学, 2019, 25(3):446-447. |
[8] | HUEGEL U, SURBEK D, MOSIMANN B, et al. Radiation- and contrast medium-free catheter-directed thrombolysis for early pregnancy-related massive iliocaval deep venous thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2019, 7(1):122-125. |
[9] |
MCCULLOUGH M, KHOLDANI C, ZAMANIAN R T. Prevention of deep vein thrombosis and pulmonary embolism in high-risk medical patients[J]. Clin Chest Med, 2018, 39(3):483-492.
DOI PMID |
[10] |
IMBERTI D, BECATTINI C, BERNARDI E, et al. Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis:a consensus on diagnosis,traditional therapy and therapy with rivaroxaban[J]. Intern Emerg Med, 2018, 13(7):1037-1049.
DOI |
[11] |
WALLACE R, ANDERSON M A, SEE K, et al. Venous thromboembolism management practices and knowledge of guidelines:a survey of Australian haematologists and respiratory physicians[J]. Intern Med J, 2017, 47(4):436-446.
DOI URL |
[12] | 邹亦庐, 吴建波, 胡继芬, 等. Caprini血栓风险评估表评估妊娠期及产褥期静脉血栓栓塞疾病风险的有效性研究[J]. 中国实用妇科与产科杂志, 2017, 33(11):1178-1182. |
[13] | 白黎峰, 张倩, 郑院青, 等. 血清Hcy、D-D、FIB联合预测急性肺血栓栓塞患者远期预后不良的价值探讨[J]. 临床肺科杂志, 2021, 26(5):718-722. |
[14] |
GÖBEL K, EICHLER S, WIENDL H, et al. The coagulation factors fibrinogen,thrombin,and factor Ⅻ in inflammatory disorders-a systematic review[J]. Front Immunol, 2018, 9:1731.
DOI URL |
[15] |
OBRADOVIC M, ZARIC B L, HAIDARA M A, et al. Link between homocysteine and cardiovascular diseases[J]. Current Pharmacology Reports, 2018, 4:1-9.
DOI URL |
[16] |
KORKMAZ H I, HAHN N E, JANSEN K M, et al. Homocysteine-induced inverse expression of tissue factor and DPP4 in endothelial cells is related to NADPH oxidase activity[J]. Physiol Int, 2019, 106(1):29-38.
DOI PMID |
[17] |
REDDY R, BIRADAR S, RAKESH M. A case of pulmonary thromboembolism secondary to hyperhomocysteinemia[J]. APIK J Int Med, 2019, 7:82-83.
DOI URL |
[18] | SASAKI T, NAKAMURA K, MINAMI K, et al. Prevalence and characteristics of venous thrombosis after catheter ablation of atrial fibrillation in patients receiving periprocedural direct oral anticoagulants[J]. J Atr Fibrillation, 2018, 11(4):2090. |
[19] |
WANG J, XU M, SUN N, et al. Factors associating with the presence of residual thrombosis after 3-month treatment of acute pulmonary embolism[J]. J Thromb Thrombolysis, 2018, 45(1):27-35.
DOI URL |
[20] | 蔡欣, 郑元杰. Hcy、FIB、hs-CRP及D-D联合检测对下肢深静脉血栓形成的诊断价值[J]. 血管与腔内血管外科杂志, 2019, 5(4):354-356. |
[21] | 任一梦, 李军民, 郭子昆. D-二聚体、BNP及PCT预测长期卧床患者下肢深静脉血栓的价值研究[J]. 深圳中西医结合杂志, 2023, 33(4):28-30. |
[1] | ZHAO Eryu, LI Yujie, YU Ting, ZHANG Yan, YE Quan, LONG Yunxia, MA Xiaoyun, WANG Xiaoyan. Analysis of hereditary dysfibrinogenemia caused by FGG gene Ala315Gly missense mutation [J]. Laboratory Medicine, 2024, 39(2): 143-148. |
[2] | ZHANG Xin, MA Lijuan. Role of cardiac markers in children [J]. Laboratory Medicine, 2023, 38(6): 505-509. |
[3] | YIN Ya, PAN Yuan, ZHOU Hongwei, SHEN Wei. Application progress of BNP and NT-proBNP in neonates [J]. Laboratory Medicine, 2023, 38(6): 518-523. |
[4] | LI Li, SUN Haiyan, LI Yuanrui, DOU Min, TANG Wen, JIANG Limin, SHEN Lisong. Changes and clinical roles of perioperative NT-proBNP and PCT in children with congenital heart disease [J]. Laboratory Medicine, 2023, 38(6): 524-531. |
[5] | LIU Yanan, XIA Min, HU Shaohua, ZHENG Yue, ZHANG Hong. Roles of lymphocyte subsets,inflammatory factors and NT-proBNP in diagnosis of Kawasaki disease [J]. Laboratory Medicine, 2023, 38(6): 532-537. |
[6] | DENG Xu, ZHUANG Wenlong, XUE Hui, ZHU Shuqin, LI Ying. Relationship between neutrophil/lymphocyte ratio,fibrinogen and carotid intima-media thickness in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2023, 38(4): 368-372. |
[7] | ZHENG Zhiyou, LI Xingzhao, XIE Yage. Changes and clinical significance of HbA1c,NT-proBNP,Hcy,SOD and TC levels in patients with diabetes cardiomyopathy [J]. Laboratory Medicine, 2023, 38(3): 282-286. |
[8] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[9] | AN Yinghong, YAO Kechun, SU Chengming, TANG Jinhua, YANG Lixin, GAO Jie, XU Yanting, YAN Qiuhong, ZHAN Hongyan, MA Yueyun. Survey of serum homocysteine levels of apparently healthy subjects in Beijing [J]. Laboratory Medicine, 2023, 38(11): 1036-1040. |
[10] | CHANG Huijun, ZHANG Min, ZHANG Qixiang. Correlation between serum homocysteine level and short-term prognosis of acute cerebral infarction patients receiving intravenous thrombolysis [J]. Laboratory Medicine, 2023, 38(11): 1057-1061. |
[11] | JIN Zhonggan, JU Yi, ZHANG Sujie. Analysis of homocysteine trueness verification results in 2021 [J]. Laboratory Medicine, 2023, 38(10): 967-970. |
[12] | SHI Penghui, FAN Weiguang, ZHANG Zhen, SU Miaomiao, MENG Juan, LU Xinli. Dynamic changes and clinical significance of CXCR5,sPD-1 and Hcy in AIDS patients during therapy [J]. Laboratory Medicine, 2022, 37(2): 103-107. |
[13] | WANG Shan, XU Minyi, WANG Wei, JIANG Mingming, LU Pei, XIONG Zhongbo, WANG Lei. Clinical value of MTHFR gene C677T polymorphism determination in patients with H-type hypertension [J]. Laboratory Medicine, 2022, 37(11): 1012-1016. |
[14] | KONG Fanbin, YUAN Yong, JI Yong, LI Zheng, CHEN Qi, WU Xiaoming, GAO Hui. Correlation between serum retinol binding protein 4,homocysteine and blood lipid with atherosclerosis [J]. Laboratory Medicine, 2021, 36(5): 467-470. |
[15] | DING Ning, ZHANG Weifeng, CHEN Xiaoyong, ZHAO Kewen. Correlations of mean platelet volume,D-dimer and fibrinogen degradation product levels with cerebral infarction and its pathological degree [J]. Laboratory Medicine, 2021, 36(4): 384-387. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||